Prosecution Insights
Prosecution Insights
Technology areas: Biotechnology & Pharmaceuticals • Medical Devices & Mechanical Engineering
7 pending office actions • 6 art units • 7 examiners • 0 of 7 (0%) have an AI response strategy ready • 5 patents granted in the last 365 days
Singapore Health Services Pte. Ltd. currently manages 7 pending office actions within the Biotechnology & Pharmaceuticals technology area. These matters are distributed across 6 distinct art units, indicating a diverse range of subject matter within the life sciences sector. The portfolio involves 7 distinct examiners, showing a decentralized prosecution environment where no single individual handles a majority of the workload.
Andrew W. Bee is the busiest examiner for this portfolio, though he is currently responsible for only 1 pending office action. This distribution suggests that the 7 pending office actions are spread evenly across the 7 distinct examiners. Practitioners should prepare for varied examination styles given the lack of examiner concentration across the 6 distinct art units. Each of the 1 pending office actions assigned to the busiest examiner represents a unique case.
With the current cases spread across multiple technical groups, the company maintains a broad technical footprint. This variety requires a flexible approach to prosecution, as the assigned examiners likely represent a wide range of perspectives within the Biotechnology & Pharmaceuticals field. Andrew W. Bee's role as the busiest examiner with 1 pending office action highlights the fragmentation of the current cases.
Based on the USPTO statutory response window for each pending office action. 2 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 3 (43%) |
| Double-patenting + other | 2 (29%) |
| Multi-statute (no §101) | 2 (29%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| BEE, ANDREW W. | 1 | 73.2% | +31.8% |
| CHO, DAVID H | 1 | 31.9% | +67.0% |
| KUO, JONATHAN T | 1 | 72.3% | +28.3% |
| LEBRON DE JESUS, GRACIELA NATALIA | 1 | 31.3% | +70.9% |
| MOLOYE, TITILAYO | 1 | 62.5% | +47.9% |
| BORGEEST, CHRISTINA M | 1 | 55.6% | +21.4% |
| KAPUSHOC, STEPHEN THOMAS | 1 | 46.5% | +53.5% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 5 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18568617 | Method of Predicting the Likelihood of Hyperglycemia | KUO, JONATHAN T | 11d overdue |
| 17796293 | Biomarkers for Risk Prediction of Parkinson's Disease | KAPUSHOC, STEPHEN THOMAS | 27d |
| 18665536 | SYSTEM AND METHOD FOR SEGMENTING MEDICAL IMAGES | BEE, ANDREW W. | — |
| 18551573 | A CONNECTOR FOR A FLUIDIC CIRCUIT | LEBRON DE JESUS, GRACIELA NATALIA | — |
| 18006136 | A METHOD OF GENERATING AN INDUCED PLURIPOTENT STEM CELL, AN INDUCED PLURIPOTENT STEM CELL AND METHODS OF USING THE INDUCED PLURIPOTENT STEM CELL | MOLOYE, TITILAYO | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 7 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18568617 | Method of Predicting the Likelihood of Hyperglycemia | KUO, JONATHAN T | 11d overdue |
| 17796293 | Biomarkers for Risk Prediction of Parkinson's Disease | KAPUSHOC, STEPHEN THOMAS | 27d |
| 18665536 | SYSTEM AND METHOD FOR SEGMENTING MEDICAL IMAGES | BEE, ANDREW W. | — |
| 18690862 | Green Tea-based Nanocomplexes for Eye Disease | CHO, DAVID H | — |
| 18551573 | A CONNECTOR FOR A FLUIDIC CIRCUIT | LEBRON DE JESUS, GRACIELA NATALIA | — |
| 18006136 | A METHOD OF GENERATING AN INDUCED PLURIPOTENT STEM CELL, AN INDUCED PLURIPOTENT STEM CELL AND METHODS OF USING THE INDUCED PLURIPOTENT STEM CELL | MOLOYE, TITILAYO | — |
| 18052426 | IMMUNOSUPPRESSIVE COMPOSITION FOR USE IN TREATING IMMUNOLOGICAL DISORDERS | BORGEEST, CHRISTINA M | — |
| Art Unit | Apps |
|---|---|
| 2669 | 1 |
| 3792 | 1 |
| 3785 | 1 |
| 1632 | 1 |
| 1675 | 1 |
| 1683 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18665536 | SYSTEM AND METHOD FOR SEGMENTING MEDICAL IMAGES | BEE, ANDREW W. | 2669 | §101§102§103 | Non-Final OA | — | Pending | May 15, 2024 |
| 18690862 | Green Tea-based Nanocomplexes for Eye Disease | CHO, DAVID H | — | §102§103§112DP | Non-Final OA | — | Pending | Mar 11, 2024 |
| 18568617 | Method of Predicting the Likelihood of Hyperglycemia | KUO, JONATHAN T | 3792 | §101§102 | Non-Final OA | 11d overdue | Pending | Dec 08, 2023 |
| 18551573 | A CONNECTOR FOR A FLUIDIC CIRCUIT | LEBRON DE JESUS, GRACIELA NATALIA | 3785 | §102§103 | Non-Final OA | — | Pending | Sep 20, 2023 |
| 18006136 | A METHOD OF GENERATING AN INDUCED PLURIPOTENT STEM CELL, AN INDUCED PLURIPOTENT STEM CELL AND METHODS OF USING THE INDUCED PLURIPOTENT STEM CELL | MOLOYE, TITILAYO | 1632 | §103§112 | Non-Final OA | — | Pending | Jan 19, 2023 |
| 18052426 | IMMUNOSUPPRESSIVE COMPOSITION FOR USE IN TREATING IMMUNOLOGICAL DISORDERS | BORGEEST, CHRISTINA M | 1675 | §112DP | Final Rejection | — | Pending | Nov 03, 2022 |
| 17796293 | Biomarkers for Risk Prediction of Parkinson's Disease | KAPUSHOC, STEPHEN THOMAS | 1683 | §101§112 | Final Rejection | 27d | Pending | Jul 29, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial